PERRIGO CO PLC (PRGO) Stock Overview
USA - NYSE:PRGO - IE00BGH1M568 - Common Stock
PRGO Key Statistics, Chart & Performance
The current stock price of PRGO is 21.68 USD. In the past month the price increased by 3.56%. In the past year, price decreased by -14.31%.
PRGO Latest News, Press Relases and Analysis
PRGO Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 51.56 | 788.09B | ||
| JNJ | JOHNSON & JOHNSON | 18.33 | 458.26B | ||
| AZN | ASTRAZENECA PLC-SPONS ADR | 18.77 | 258.40B | ||
| NVS | NOVARTIS AG-SPONSORED ADR | 14.78 | 253.30B | ||
| NVO | NOVO-NORDISK A/S-SPONS ADR | 13.78 | 237.59B | ||
| MRK | MERCK & CO. INC. | 11.42 | 219.55B | ||
| PFE | PFIZER INC | 7.32 | 141.03B | ||
| SNY | SANOFI-ADR | 11.72 | 125.68B | ||
| GSK | GSK PLC-SPON ADR | 9.65 | 86.92B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 6.51 | 89.16B | ||
| ZTS | ZOETIS INC | 23.55 | 64.93B | ||
| TAK | TAKEDA PHARMACEUTIC-SP ADR | 50.04 | 44.25B |
Related stock screener links
About PRGO
Company Profile
Perrigo Co. Plc is a pure-play self-care company provider of consumer self-care products and over-the-counter (OTC) health and wellness solutions that enhance individual well-being by empowering consumers to proactively prevent or treat conditions that can be self-managed. The company is headquartered in Dublin, Dublin and currently employs 8,379 full-time employees. Its segments include Consumer Self-Care Americas (CSCA) and Consumer Self-Care International (CSCI). The CSCA segment comprises of its consumer self-care business in the United States and Canada. The company primarily provides its customers self-care products that are sold and marketed under the customer's own brands and/or exclusive brands. The CSCI segment comprises of its consumer self-care business outside of the United States and Canada, primarily in Europe and Australia. These products are developed, manufactured, marketed, and distributed by the Company. Its product categories include Upper Respiratory, Pain and Sleep-Aids, Skincare and Personal Hygiene, Digestive Health, and Nutrition. Its primary branded products are sold under brand names Compeed, Dr. Fresh, Firefly, Good Sense, Mederma, Nasonex, Solpadeine, Coldrex, and Physiomer, among others.
Company Info
PERRIGO CO PLC
The Sharp Building, Hogan Place, Dublin 2
DUBLIN DUBLIN 49010 IE
CEO: Murray S. Kessler
Employees: 8379
Phone: 3532696738451
PERRIGO CO PLC / PRGO FAQ
What does PERRIGO CO PLC do?
Perrigo Co. Plc is a pure-play self-care company provider of consumer self-care products and over-the-counter (OTC) health and wellness solutions that enhance individual well-being by empowering consumers to proactively prevent or treat conditions that can be self-managed. The company is headquartered in Dublin, Dublin and currently employs 8,379 full-time employees. Its segments include Consumer Self-Care Americas (CSCA) and Consumer Self-Care International (CSCI). The CSCA segment comprises of its consumer self-care business in the United States and Canada. The company primarily provides its customers self-care products that are sold and marketed under the customer's own brands and/or exclusive brands. The CSCI segment comprises of its consumer self-care business outside of the United States and Canada, primarily in Europe and Australia. These products are developed, manufactured, marketed, and distributed by the Company. Its product categories include Upper Respiratory, Pain and Sleep-Aids, Skincare and Personal Hygiene, Digestive Health, and Nutrition. Its primary branded products are sold under brand names Compeed, Dr. Fresh, Firefly, Good Sense, Mederma, Nasonex, Solpadeine, Coldrex, and Physiomer, among others.
What is the current price of PRGO stock?
The current stock price of PRGO is 21.68 USD. The price increased by 0.84% in the last trading session.
Does PERRIGO CO PLC pay dividends?
PERRIGO CO PLC (PRGO) has a dividend yield of 5.39%. The yearly dividend amount is currently 1.12.
What is the ChartMill technical and fundamental rating of PRGO stock?
PRGO has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
What is the analyst forecast for PRGO stock?
10 analysts have analysed PRGO and the average price target is 34.17 USD. This implies a price increase of 57.61% is expected in the next year compared to the current price of 21.68.
Can you provide the PE ratio for PRGO stock?
The PE ratio for PERRIGO CO PLC (PRGO) is 7.45. This is based on the reported non-GAAP earnings per share of 2.91 and the current share price of 21.68 USD.
What is the expected growth for PRGO stock?
The Revenue of PERRIGO CO PLC (PRGO) is expected to decline by -1.04% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
PRGO Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to PRGO. When comparing the yearly performance of all stocks, PRGO is a bad performer in the overall market: 87.4% of all stocks are doing better.
PRGO Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to PRGO. PRGO has a medium profitability rating, but doesn't score so well on its financial health evaluation.
PRGO Financial Highlights
Over the last trailing twelve months PRGO reported a non-GAAP Earnings per Share(EPS) of 2.91. The EPS increased by 25.43% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -0.8% | ||
| ROE | -1.8% | ||
| Debt/Equity | 0.81 |
PRGO Forecast & Estimates
10 analysts have analysed PRGO and the average price target is 34.17 USD. This implies a price increase of 57.61% is expected in the next year compared to the current price of 21.68.
For the next year, analysts expect an EPS growth of 19.13% and a revenue growth -1.04% for PRGO